Humana to offer LabCorp at-home COVID-19 test collection

Media Statement: Testing demand and result timeframe*

Original statement posted on June 27.*Updated June 30

Labcorp introduces Xcellerate® COVID-19 clinical study solution

LabCorp introduces Xcellerate® COVID-19 clinical study solution

Advanced Analytics and Visualizations Empower Study Teams to Respond to Dynamic Environment, Manage Risk, Resume Studies and Safeguard Patients

Labcorp launches new neutralizing antibody test

Neutralizing Antibody Assay Could Be Used to Assist in Development of COVID-19 Vaccines and Plasma-Based Treatments

Brian Caveney, Chief Medical Officer and President of LabCorp Diagnostics, named to Modern Healthcare's 50 Most Influential Clinical Executives List

BURLINGTON, N.C., June 16, 2020 — LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that Dr. Brian Caveney, chief medical officer and president of LabCorp Diagnostics, was recognized by Modern Healthcare as one of this year’s 50 Most Influential Clinical Executives.